
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Cefepime Neonatal Dosing Guidelines</title>
    <style>
        body { font-family: Arial, sans-serif; margin: 20px; line-height: 1.6; }
        h1 { color: #2E4372; }
        table { width: 100%; border-collapse: collapse; margin-bottom: 20px; }
        th, td { border: 1px solid #aaa; padding: 8px; text-align: center; }
        th { background-color: #f2f2f2; }
        .note { font-size: 0.95em; color: #555; margin-bottom: 20px; }
    </style>
</head>
<body>
    <h1>Cefepime Neonatal Dosing Guidelines</h1>

    <p><strong>General dosing, susceptible infection:</strong> Limited data available:</p>

    <h2>Age-directed dosing</h2>
    <p class="note">Note: Dosing based on pharmacokinetic evaluations and modeling from neonates and young infants, including patients with GA ranging from 22 to 42 weeks.</p>
    <table>
        <thead>
            <tr>
                <th>Postnatal Age</th>
                <th>Dose</th>
            </tr>
        </thead>
        <tbody>
            <tr>
                <td>&lt;30 days</td>
                <td>30 to 50 mg/kg/dose every 12 hours<sup>a</sup></td>
            </tr>
            <tr>
                <td>&ge;30 days</td>
                <td>50 mg/kg/dose every 8 hours<sup>b</sup></td>
            </tr>
        </tbody>
    </table>

    <h2>Weight-directed dosing</h2>
    <table>
        <thead>
            <tr>
                <th>Body Weight</th>
                <th>Postnatal Age</th>
                <th>Dose</th>
            </tr>
        </thead>
        <tbody>
            <tr>
                <td>&le;2 kg</td>
                <td>&le;28 days</td>
                <td>30 mg/kg/dose every 12 hours</td>
            </tr>
            <tr>
                <td>&le;2 kg</td>
                <td>29 to 60 days</td>
                <td>50 mg/kg/dose every 8 hours<sup>a</sup></td>
            </tr>
            <tr>
                <td>&gt;2 kg</td>
                <td>&le;28 days</td>
                <td>50 mg/kg/dose every 12 hours</td>
            </tr>
            <tr>
                <td>&gt;2 kg</td>
                <td>29 to 60 days</td>
                <td>50 mg/kg/dose every 8 hours<sup>a</sup></td>
            </tr>
        </tbody>
    </table>

    <p class="note"><sup>a</sup>If pathogen MIC is ≥8 mg/L, doses may need to be infused over 3 hours or frequency increased to every 6 hours.</p>
    <p class="note"><sup>b</sup>If pathogen MIC is ≥8 mg/L, doses may need to be infused over 3 hours or frequency increased to every 6 hours to achieve desired time > MIC.</p>

    <h2>ECLS/ECMO Considerations</h2>
    <p>Components of ECLS/ECMO circuit and pathophysiological changes during critical illness influence the pharmacokinetics of a drug. Monitor patient response closely and refer to institutional protocols.</p>
    <p>Administer medication via the patient's vascular access when possible. If unavailable, ECLS/ECMO circuit administration is acceptable.</p>

    <h2>Infection Treatment</h2>
    <p>No general dosage adjustment is typically recommended initially. Adjust based on patient-specific factors (e.g., birthweight, kidney function, site of infection, pathogen MIC), clinical response, and therapeutic drug monitoring.</p>

    <h2>Concomitant Therapy</h2>
    <p>Significant drug interactions exist. Consult drug interaction databases for appropriate adjustment or avoidance.</p>
</body>
</html>
